Page last updated: 2024-08-18

quinuclidines and Long QT Syndrome

quinuclidines has been researched along with Long QT Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, EK; Hong, DM; Jeon, Y; Jung, YS; Kim, HJ; Lee, HC; Lee, J; Min, JJ; Oh, S1
Brealey, N; Kelleher, D; Mehta, R; Preece, A; Tombs, L1
Brygger, L; Herrstedt, J1

Reviews

1 review(s) available for quinuclidines and Long QT Syndrome

ArticleYear
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.
    Expert opinion on drug safety, 2014, Volume: 13, Issue:10

    Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2014

Trials

2 trial(s) available for quinuclidines and Long QT Syndrome

ArticleYear
Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia.
    British journal of anaesthesia, 2014, Volume: 112, Issue:3

    Topics: Adult; Aged; Anesthesia, Inhalation; Anesthetics, Inhalation; Antiemetics; Blood Pressure; Double-Blind Method; Electrocardiography; Electrolytes; Female; Heart Rate; Humans; Isoquinolines; Long QT Syndrome; Male; Methyl Ethers; Middle Aged; Monitoring, Intraoperative; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Sevoflurane; Treatment Outcome; Young Adult

2014
A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Pulmonary pharmacology & therapeutics, 2014, Volume: 29, Issue:1

    Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Chlorobenzenes; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Dry Powder Inhalers; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Quinuclidines; Single-Blind Method; Young Adult

2014